Nerve growth factor receptors and signaling in breast cancer

被引:79
作者
Dollé, L
Adriaenssens, E
El Yazidi-Belkoura, I
Le Bourhis, X
Nurcombe, V
Hondermarck, H
机构
[1] INSERM, EA 1033, ESPRI, UPRES, F-59655 Villeneuve Dascq, France
[2] Univ Sci & Tech Lille Flandres Artois, IFR 118, Growth Factor Signaling Breast Canc Funct Proteom, Lille, France
[3] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia
关键词
breast cancer; nerve growth factor; receptors and signaling; therapeutic target;
D O I
10.2174/1568009043332853
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nerve growth factor (NGF) has long been known for its effects on neuronal cell survival and differentiation. This prototypical neurotrophic factor stimulates neurons through two distinct classes of membrane receptors: the TrkA tyrosine kinase receptor, and the tumor necrosis factor receptor family member p75(NTR), also known as the common neurotrophin receptor. Somewhat surprisingly, there is a growing body of evidence indicating that NGF is also a major stimulator of breast cancer cell growth. Both the survival and proliferation of breast cancer cells are strongly stimulated by NGF, mediated by TrkA and p75(NTR) respectively, utilising signaling pathways similar to those described for neurons. In addition, although NGF is produced by breast cancer cells, it is not in normal breast epithelial cells, giving rise to an autocrine stimulation of tumor growth. Therefore, NGF receptors and signaling are thus looking increasingly promising as potential drug targets for breast cancer.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 35 条
[1]   Endocrine-responsive breast cancer and strategies for combating resistance [J].
Ali, S ;
Coombes, RC .
NATURE REVIEWS CANCER, 2002, 2 (02) :101-+
[2]   NERVE GROWTH-FACTOR AND ITS LOW-AFFINITY RECEPTOR PROMOTE SCHWANN-CELL MIGRATION [J].
ANTON, ES ;
WESKAMP, G ;
REICHARDT, LF ;
MATTHEW, WD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2795-2799
[3]   Nerve growth factor receptor immunoreactivity in breast cancer patients [J].
Aragona, M ;
Panetta, S ;
Silipigni, AM ;
Romeo, DL ;
Pastura, G ;
Mesiti, M ;
Cascinu, S ;
La Torre, F .
CANCER INVESTIGATION, 2001, 19 (07) :692-697
[4]   Molecular targets for breast cancer therapy and prevention [J].
Bange, J ;
Zwick, E ;
Ullrich, A .
NATURE MEDICINE, 2001, 7 (05) :548-552
[5]   FGF signals for cell proliferation and migration through different pathways [J].
Boilly, B ;
Vercoutter-Edouart, AS ;
Hondermarck, H ;
Nurcombe, V ;
Le Bourhis, X .
CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (04) :295-302
[6]   Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma [J].
Bonini, S ;
Lambiase, A ;
Bonini, S ;
Angelucci, F ;
Magrini, L ;
Manni, L ;
Aloe, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10955-10960
[7]   Tumour marker measurements in the diagnosis and monitoring of breast cancer [J].
Cheung, KL ;
Graves, CRL ;
Robertson, JFR .
CANCER TREATMENT REVIEWS, 2000, 26 (02) :91-102
[8]  
Chiarenza A, 2001, CANCER RES, V61, P3002
[9]   Herceptin: From the bench to the clinic [J].
Colomer, R ;
Shamon, LA ;
Tsai, MS ;
Lupu, R .
CANCER INVESTIGATION, 2001, 19 (01) :49-56
[10]   Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells [J].
Descamps, S ;
Lebourhis, X ;
Delehedde, M ;
Boilly, B ;
Hondermarck, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :16659-16662